Amelia McCartney

Metabolomics to Assess Response to Immune Checkpoint Inhibitors in Patients with Non-Small-Cell Lung Cancer

Veronica Ghini, Letizia Laera, Beatrice Fantechi et al. · Cancers · 2020 · 132 citations · Full text

Palbociclib as single agent or in combination with the endocrine therapy received before disease progression for estrogen receptor-positive, HER2-negative metastatic breast cancer: TREnd trial

Luca Malorni, Giuseppe Curigliano, Alessandro Marco Minisini et al. · Annals of Oncology · 2018 · 94 citations · Full text

Plasma Thymidine Kinase Activity as a Biomarker in Patients with Luminal Metastatic Breast Cancer Treated with Palbociclib within the TREnd Trial

Amelia McCartney, Martina Bonechi, Francesca De Luca et al. · Clinical Cancer Research · 2020 · 54 citations · Full text

Prognostic role of serum thymidine kinase 1 activity in patients with hormone receptor–positive metastatic breast cancer: Analysis of the randomised phase III Evaluation of Faslodex versus Exemestane Clinical Trial (EFECT)

Amelia McCartney, Chiara Biagioni, Gaia Schiavon et al. · European Journal of Cancer · 2019 · 40 citations

Breast Oncology, Prognostic Role, Medicine +8

Circulating tumor cells and palbociclib treatment in patients with ER-positive, HER2-negative advanced breast cancer: results from a translational sub-study of the TREnd trial

Francesca Galardi, Francesca De Luca, Chiara Biagioni et al. · Breast Cancer Research · 2021 · 32 citations · Full text